A clinical study on cefdinir in pediatrics

Y. Satoh, S. Iwata, H. Akita, K. Sunakawa

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Clinical evaluations of cefdinir (CDFN, FK 482) were carried out. The obtained results are summarized as follows. 1. Clinical responses to CFDN of 43 patients with pediatric infections were excellent in 23, good in 15, fair in 4 and poor in 1. The overall efficacy rate was 88%. 2. Bacteriologically, the eradication rate for 34 isolates presumed to be pathogens was evaluated and the eradication rate was 85.3%. 3. Side effects observed were diarrhea in 4 of 48 patients. The incidence was 8.3%. Abnormal laboratory findings were an elevation of GOT, an elevation of eosinophile and an increase in platelet counts. The results suggested that CFDN might be a very useful and safe drug for the treatment of pediatric infections.

Original languageEnglish
Pages (from-to)1796-1805
Number of pages10
JournalJapanese Journal of Antibiotics
Volume43
Issue number10
Publication statusPublished - 1990
Externally publishedYes

Fingerprint

cefdinir
Pediatrics
Infection
Platelet Count
Eosinophils
Diarrhea
Clinical Studies
Incidence
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology

Cite this

Satoh, Y., Iwata, S., Akita, H., & Sunakawa, K. (1990). A clinical study on cefdinir in pediatrics. Japanese Journal of Antibiotics, 43(10), 1796-1805.

A clinical study on cefdinir in pediatrics. / Satoh, Y.; Iwata, S.; Akita, H.; Sunakawa, K.

In: Japanese Journal of Antibiotics, Vol. 43, No. 10, 1990, p. 1796-1805.

Research output: Contribution to journalArticle

Satoh, Y, Iwata, S, Akita, H & Sunakawa, K 1990, 'A clinical study on cefdinir in pediatrics', Japanese Journal of Antibiotics, vol. 43, no. 10, pp. 1796-1805.
Satoh Y, Iwata S, Akita H, Sunakawa K. A clinical study on cefdinir in pediatrics. Japanese Journal of Antibiotics. 1990;43(10):1796-1805.
Satoh, Y. ; Iwata, S. ; Akita, H. ; Sunakawa, K. / A clinical study on cefdinir in pediatrics. In: Japanese Journal of Antibiotics. 1990 ; Vol. 43, No. 10. pp. 1796-1805.
@article{b09c52c07fa944468a35f9d05dd9573e,
title = "A clinical study on cefdinir in pediatrics",
abstract = "Clinical evaluations of cefdinir (CDFN, FK 482) were carried out. The obtained results are summarized as follows. 1. Clinical responses to CFDN of 43 patients with pediatric infections were excellent in 23, good in 15, fair in 4 and poor in 1. The overall efficacy rate was 88{\%}. 2. Bacteriologically, the eradication rate for 34 isolates presumed to be pathogens was evaluated and the eradication rate was 85.3{\%}. 3. Side effects observed were diarrhea in 4 of 48 patients. The incidence was 8.3{\%}. Abnormal laboratory findings were an elevation of GOT, an elevation of eosinophile and an increase in platelet counts. The results suggested that CFDN might be a very useful and safe drug for the treatment of pediatric infections.",
author = "Y. Satoh and S. Iwata and H. Akita and K. Sunakawa",
year = "1990",
language = "English",
volume = "43",
pages = "1796--1805",
journal = "The Journal of antibiotics. Ser. B",
issn = "0368-2781",
publisher = "Japan Antibiotics Research Association",
number = "10",

}

TY - JOUR

T1 - A clinical study on cefdinir in pediatrics

AU - Satoh, Y.

AU - Iwata, S.

AU - Akita, H.

AU - Sunakawa, K.

PY - 1990

Y1 - 1990

N2 - Clinical evaluations of cefdinir (CDFN, FK 482) were carried out. The obtained results are summarized as follows. 1. Clinical responses to CFDN of 43 patients with pediatric infections were excellent in 23, good in 15, fair in 4 and poor in 1. The overall efficacy rate was 88%. 2. Bacteriologically, the eradication rate for 34 isolates presumed to be pathogens was evaluated and the eradication rate was 85.3%. 3. Side effects observed were diarrhea in 4 of 48 patients. The incidence was 8.3%. Abnormal laboratory findings were an elevation of GOT, an elevation of eosinophile and an increase in platelet counts. The results suggested that CFDN might be a very useful and safe drug for the treatment of pediatric infections.

AB - Clinical evaluations of cefdinir (CDFN, FK 482) were carried out. The obtained results are summarized as follows. 1. Clinical responses to CFDN of 43 patients with pediatric infections were excellent in 23, good in 15, fair in 4 and poor in 1. The overall efficacy rate was 88%. 2. Bacteriologically, the eradication rate for 34 isolates presumed to be pathogens was evaluated and the eradication rate was 85.3%. 3. Side effects observed were diarrhea in 4 of 48 patients. The incidence was 8.3%. Abnormal laboratory findings were an elevation of GOT, an elevation of eosinophile and an increase in platelet counts. The results suggested that CFDN might be a very useful and safe drug for the treatment of pediatric infections.

UR - http://www.scopus.com/inward/record.url?scp=0025244206&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025244206&partnerID=8YFLogxK

M3 - Article

VL - 43

SP - 1796

EP - 1805

JO - The Journal of antibiotics. Ser. B

JF - The Journal of antibiotics. Ser. B

SN - 0368-2781

IS - 10

ER -